Insider · CIK 0002051249
Gary D Glick
Files at ODTX (Odyssey Therapeutics, Inc.). First filing -, latest -.
In brief
Gary D Glick files SEC Form 4 as officer and director at ODTX (Odyssey Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gary D Glick has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ODTX Odyssey Therapeutics, Inc. | CConversion Common Stock | +27,386 | - | - | 415,973 | May 11, 2026 |
| May 11, 2026 | ODTX Odyssey Therapeutics, Inc. | CConversion Series C Convertible Preferred Stockderivative | -100,000 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | ODTX Odyssey Therapeutics, Inc. | CConversion Series D Convertible Preferred Stockderivative | -166,116 | - | - | 0 | May 11, 2026 |
| May 7, 2026 | ODTX Odyssey Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +884,450 | $0.00 | $0 | 884,450 | May 11, 2026 |
Questions about Gary D Glick
Answered from the filings on this page, as of the latest one.
Is Gary D Glick buying or selling?
Gary D Glick has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gary D Glick's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gary D Glick has 0.
Where does Gary D Glick file Form 4?
Gary D Glick has filed Form 4 at ODTX (Odyssey Therapeutics, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.